Staff Reports
Telehealth promised convenience and access. What it delivered in this case was fast refills, flashy ads, and a criminal business model that treated patients like monthly subscriptions. This week, federal courts finally put a stop to that abuse when the founder and clinical president of a digital mental‑health company were sentenced for a nationwide Adderall distribution and health‑care fraud scheme.
Sentenced for a growth-at-all-costs scheme
Ruthia He, founder and former CEO of Done Global Inc., was sentenced to 72 months in prison and ordered to pay a $1 million fine after a jury convicted her of running a conspiracy that illegally distributed more than 37 million Adderall pills and defrauded insurers of roughly $12 million. Her former clinical president, David Brody, drew a 24‑month sentence and a $1 million fine. Assistant Attorney General Colin M. McDonald put it bluntly: “Ruthia He hid behind the cloak of medicine to deceive the public, defraud health care programs, and unlawfully deal highly addictive drugs to vulnerable patients.” Those are harsh words — and they fit.
How the telehealth model was weaponized
Prosecutors showed how technology, incentives, and slick advertising were stitched together to corrupt medical care. The company spent more than $40 million on targeted social‑media ads and promoted a subscription‑for‑prescription model with auto‑refills. Clinicians were allegedly paid huge sums to sign refills quickly, and evidence showed refill approvals happened in seconds. As prosecutors noted, the platform even kept refilling prescriptions after hospitalizations and, in some shocking cases, after patients had died. DEA Administrator Terrance Cole warned that whether drugs move on a street corner or on an app, “the motive and the resulting harm are the same.”
A warning to investors, boards, and telehealth CEOs
This case isn’t just about two executives. It’s a warning to venture capitalists, boards, and startups that treat medical care like a growth metric. When a business model puts valuation ahead of patient safety, regulators will step in. U.S. Attorney Craig H. Missakian said it plainly: “Drug traffickers are driven by profits, not people.” If your code and incentive plan reward prescriptions instead of good medicine, expect scrutiny — and criminal exposure.
Telehealth can be a force for good. But without firm rules and rigorous oversight, it becomes another way to gamify health care and prey on vulnerable people. Regulators are tightening the screws. Lawmakers and industry leaders should stop pretending profit and patient care always go hand in hand. Stronger rules, tougher audits, and clear criminal accountability for executives are the commonsense steps that will protect patients and taxpayers — and prevent a repeat of this ugly chapter in telemedicine.
